Delivery Order SPE2DB24D3013-SPE2DB25FFNRW
Award Date 7/24/25
Potential Completion Date 7/25/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Myrbetriq ER 25 mg tablets (90-count supply) with a contract ceiling value of $7,101.28. The award, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,248.63 by the Defense Logistics Agency on July 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count packaging). The contract employs firm fixed pricing and carries an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate office and primary distribution hub...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a Delivery Order valued at $9,586.26 by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Myrbetriq ER 25 mg tablets (90-count). This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 13, 2025, and represents a non-set-aside procurement. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $3,977.47. This contract represents a firm fixed-price delivery order under a competitive, non-set-aside procurement and is scheduled for completion by July 25, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office and serves...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $36,113.23 on July 29, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- AmerisourceBergen Drug Corp has been awarded a delivery order from the Defense Logistics Agency for $12,459.55 to supply Myrbetriq ER 50 mg tablets in a 90-count quantity. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and utilizes firm fixed pricing with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order represents a competitive...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $29,045.67 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Myrbetriq ER 50 mg tablets in a 90-count configuration, with a ceiling value of $6,187.69. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $18,945.55. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $83,835.22 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The product will be...